Literature DB >> 27041563

The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma.

T Muramatsu1,2,3, K-I Kozaki1,4,5, S Imoto6, R Yamaguchi6, H Tsuda7, T Kawano8, N Fujiwara1,8, M Morishita1, S Miyano6, J Inazawa1,2,4,9.   

Abstract

Metastasis is a critical factor contributing to poor prognosis in cancer, but the underlying mechanisms of metastasis are still poorly understood. We established a highly metastatic cell subline (HOC313-LM) derived from an oral squamous cell carcinoma cell line (HOC313) for uncovering the mechanisms of metastasis, and identified deoxyhypusine synthase (DHPS) as a metastasis-associated gene within the specific amplification at 19p13.2-p13.13 in HOC313-LM. DHPS-mediated hypusine-modification of eukaryotic translation factor 5A facilitated the translation of RhoA, resulting in the activation of the RhoA signaling pathway and leading to not only increased cell motility, invasion and metastasis of cancer cells in vitro, but also increased tumor growth in vivo. Moreover, the use of N1-Guanyl-1,7-diaminoheptane, a DHPS inhibitor, resulted in a significant decrease in tumor formation in vivo. In patients with esophageal squamous cell carcinoma (ESCC), overexpression of DHPS in ESCC tumors was significantly associated with worse recurrence-free survival, and correlated with distant metastasis. The elucidation of these molecular mechanisms within the hypusine cascade suggests opportunities for novel therapeutic targets in SCC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27041563     DOI: 10.1038/onc.2016.71

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  55 in total

Review 1.  Crossing the endothelial barrier during metastasis.

Authors:  Nicolas Reymond; Bárbara Borda d'Água; Anne J Ridley
Journal:  Nat Rev Cancer       Date:  2013-12       Impact factor: 60.716

2.  Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis.

Authors:  Szu-Wei Lee; Chien-Feng Li; Chia-Hsin Chan; Jing Wang; Wei-Lei Yang; Ching-Yuan Wu; Juan Wu; Keiichi I Nakayama; Hong-Yo Kang; Hsuan-Ying Huang; Mien-Chie Hung; Pier Paolo Pandolfi; Hui-Kuan Lin
Journal:  Nat Cell Biol       Date:  2010-04-11       Impact factor: 28.824

Review 3.  eIF5A isoforms and cancer: two brothers for two functions?

Authors:  M Caraglia; M H Park; E C Wolff; M Marra; A Abbruzzese
Journal:  Amino Acids       Date:  2011-12-03       Impact factor: 3.520

4.  Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.

Authors:  Dong-Jiang Tang; Sui-Sui Dong; Ning-Fang Ma; Dan Xie; Leilei Chen; Li Fu; Sze Hang Lau; Yan Li; Yan Li; Xin-Yuan Guan
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

5.  Inhibition of eukaryotic translation initiation factor 5A (eIF5A) hypusination impairs melanoma growth.

Authors:  Miriam G Jasiulionis; Augusto D Luchessi; Andreia G Moreira; Pedro P C Souza; Ana P M Suenaga; Mariangela Correa; Carlos A S Costa; Rui Curi; Claudio M Costa-Neto
Journal:  Cell Biochem Funct       Date:  2007 Jan-Feb       Impact factor: 3.685

6.  A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival.

Authors:  Kentaro Nakayama; Naomi Nakayama; Ben Davidson; Jim J-C Sheu; Natini Jinawath; Antonio Santillan; Ritu Salani; Robert E Bristow; Patrice J Morin; Robert J Kurman; Tian-Li Wang; Ie-Ming Shih
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-27       Impact factor: 11.205

Review 7.  Molecular basis of metastasis.

Authors:  Anne C Chiang; Joan Massagué
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

Review 8.  Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases.

Authors:  Robert A Casero; Laurence J Marton
Journal:  Nat Rev Drug Discov       Date:  2007-05       Impact factor: 84.694

9.  Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach.

Authors:  Stefan Balabanov; Artur Gontarewicz; Patrick Ziegler; Ulrike Hartmann; Winfried Kammer; Mhairi Copland; Ute Brassat; Martin Priemer; Ilona Hauber; Thomas Wilhelm; Gerold Schwarz; Lothar Kanz; Carsten Bokemeyer; Joachim Hauber; Tessa L Holyoake; Alfred Nordheim; Tim H Brümmendorf
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

10.  Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma.

Authors:  Ie-Ming Shih; Kentaro Nakayama; Gang Wu; Naomi Nakayama; Jinghui Zhang; Tian-Li Wang
Journal:  Mod Pathol       Date:  2011-01-14       Impact factor: 7.842

View more
  15 in total

Review 1.  Hypusinated EIF5A as a feasible drug target for Advanced Medicinal Therapies in the treatment of pathogenic parasites and therapy-resistant tumors.

Authors:  Annette Kaiser; Enzo Agostinelli
Journal:  Amino Acids       Date:  2022-01-09       Impact factor: 3.520

Review 2.  Polyamine metabolism and cancer: treatments, challenges and opportunities.

Authors:  Robert A Casero; Tracy Murray Stewart; Anthony E Pegg
Journal:  Nat Rev Cancer       Date:  2018-11       Impact factor: 60.716

3.  Differential Functions of Splicing Factors in Mammary Transformation and Breast Cancer Metastasis.

Authors:  SungHee Park; Mattia Brugiolo; Martin Akerman; Shipra Das; Laura Urbanski; Adam Geier; Anil K Kesarwani; Martin Fan; Nathan Leclair; Kuan-Ting Lin; Leo Hu; Ian Hua; Joshy George; Senthil K Muthuswamy; Adrian R Krainer; Olga Anczuków
Journal:  Cell Rep       Date:  2019-11-26       Impact factor: 9.995

4.  Chromothripsis-like chromosomal rearrangements induced by ionizing radiation using proton microbeam irradiation system.

Authors:  Maki Morishita; Tomoki Muramatsu; Yumiko Suto; Momoki Hirai; Teruaki Konishi; Shin Hayashi; Daichi Shigemizu; Tatsuhiko Tsunoda; Keiji Moriyama; Johji Inazawa
Journal:  Oncotarget       Date:  2016-03-01

5.  Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.

Authors:  Sujata Sakha; Tomoki Muramatsu; Koji Ueda; Johji Inazawa
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

6.  Subcloning and characterization of highly metastatic cells derived from human esophageal squamous cell carcinoma KYSE150 cells by in vivo selection.

Authors:  Masafumi Okuda; Jun Inoue; Naoto Fujiwara; Tatsuyuki Kawano; Johji Inazawa
Journal:  Oncotarget       Date:  2017-05-23

7.  miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer.

Authors:  Hidekazu Hiramoto; Tomoki Muramatsu; Daisuke Ichikawa; Kousuke Tanimoto; Satoru Yasukawa; Eigo Otsuji; Johji Inazawa
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

8.  Effect of the Expression of ELOVL5 and IGFBP6 Genes on the Metastatic Potential of Breast Cancer Cells.

Authors:  Sergey Nikulin; Galina Zakharova; Andrey Poloznikov; Maria Raigorodskaya; Daniel Wicklein; Udo Schumacher; Stepan Nersisyan; Jonas Bergquist; Georgy Bakalkin; Lidiia Astakhova; Alexander Tonevitsky
Journal:  Front Genet       Date:  2021-06-02       Impact factor: 4.599

Review 9.  Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism.

Authors:  Amaia Arruabarrena-Aristorena; Amaia Zabala-Letona; Arkaitz Carracedo
Journal:  Sci Adv       Date:  2018-01-24       Impact factor: 14.136

10.  A multidimensional systems biology analysis of cellular senescence in aging and disease.

Authors:  Roberto A Avelar; Javier Gómez Ortega; Robi Tacutu; Eleanor J Tyler; Dominic Bennett; Paolo Binetti; Arie Budovsky; Kasit Chatsirisupachai; Emily Johnson; Alex Murray; Samuel Shields; Daniela Tejada-Martinez; Daniel Thornton; Vadim E Fraifeld; Cleo L Bishop; João Pedro de Magalhães
Journal:  Genome Biol       Date:  2020-04-07       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.